Achieve Life Sciences, Inc. (ACHV) — 8-K Filings

8-K Filings (14)

• ACHIEVE LIFE SCIENCES Files 8-K on Financial Results — Mar 24, 2026
  ACHIEVE LIFE SCIENCES, INC. filed an 8-K on March 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial S
• Achieve Life Sciences Relocates HQ, Reports Officer/Director Changes — Oct 7, 2025 Risk: medium
  Achieve Life Sciences, Inc. announced on October 6, 2025, a change in its principal executive offices to Vancouver, BC, Canada. The company also reported on the
• Achieve Life Sciences Announces Board & Officer Changes — Sep 11, 2025 Risk: medium
  Achieve Life Sciences, Inc. announced on September 5, 2025, a series of significant corporate actions. These include the departure of certain officers and direc
• Achieve Life Sciences Files 8-K: Material Agreement & Other Events — Jun 27, 2025 Risk: medium
  On June 26, 2025, Achieve Life Sciences, Inc. entered into a material definitive agreement. The company also reported other events and filed financial statement
• Achieve Life Sciences Files 8-K on Security Holder Vote Matters — Jun 6, 2025 Risk: medium
  On June 4, 2025, Achieve Life Sciences, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The company, formerly known as
• Achieve Life Sciences Files 8-K Report — Feb 10, 2025 Risk: low
  On February 10, 2025, Achieve Life Sciences, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." The
• Achieve Life Sciences Announces Director, Officer Changes — Jan 10, 2025 Risk: medium
  Achieve Life Sciences, Inc. announced on January 6, 2025, a series of significant corporate actions. These include the election of new directors, the appointmen
• Achieve Life Sciences Announces Board and Officer Changes — Dec 9, 2024 Risk: medium
  Achieve Life Sciences, Inc. announced on December 5, 2024, a series of significant corporate actions. These include the election of new directors, the appointme
• Achieve Life Sciences Files 8-K — Sep 27, 2024 Risk: low
  Achieve Life Sciences, Inc. filed an 8-K on September 27, 2024, reporting the entry into a material definitive agreement and filing financial statements and exh
• Achieve Life Sciences Appoints New CMO, Director — Aug 26, 2024 Risk: medium
  Achieve Life Sciences, Inc. announced on August 20, 2024, the appointment of Dr. Cherise Smith as Chief Medical Officer and the election of Ms. Jennifer Cook to
• Achieve Life Sciences Raises $1M in Stock Sale — Jul 29, 2024 Risk: medium
  On July 25, 2024, Achieve Life Sciences, Inc. entered into a Material Definitive Agreement, specifically a Securities Purchase Agreement, with certain investors
• Achieve Life Sciences Files 8-K for Regulation FD Disclosure — Jun 27, 2024 Risk: low
  Achieve Life Sciences, Inc. filed an 8-K on June 27, 2024, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or mater
• Achieve Life Sciences Files 8-K on Shareholder Vote Matters — Jun 6, 2024 Risk: low
  Achieve Life Sciences, Inc. filed an 8-K on June 6, 2024, reporting on a submission of matters to a vote of security holders that occurred on June 5, 2024. The
• ACHIEVE LIFE SCIENCES Reports Material Agreements, Equity Sales — Feb 29, 2024 Risk: medium
  ACHIEVE LIFE SCIENCES, INC. filed an 8-K on February 28, 2024, reporting on several key events including the entry into and termination of material definitive a

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX